KaydedilenlerDerginizi ekleyin

Dergiler / Turkish journal of vascular surgery / 2019 / Cilt: 28 - Sayı: 2

Relationship of homocysteine level with abdominal aortic aneurysm and coronary artery disease

Deniz ŞEREFLİ
Onur SAYDAM
Sadık Kıvanç METİN
Sayfa
91–94
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

No significant differences in the homocysteine levels (p=0.072) were found both between the patients with low and high LDL-clevels (p=0.345) and between the patients with low and high triglyceride levels.Conclusion: Our study results suggest that homocysteine level is directly associated with AAAs and may be useful to identify patients withan AAA.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The aim of the present study was to investigate the relationship of homocysteine levels with major atherosclerotic diseases inpatients with coronary artery disease undergoing coronary artery bypass grafting (CABG) and in patients with infrarenal abdominal aorticaneurysms (AAAs).Patients and methods: This prospective, case-control study included a total of 55 patients (35 males, 20 females; median age 64 years; range,42 to 83 years) undergoing CABG and patients with infrarenal AAAs between January 2015 and June 2015.
📊
Temel Bulgular & Veri:The infrarenal AAA group(n=15) consisted of the patients having an anteroposterior diameter of ≥50 mm and the CABG group (n=20) consisted of the patients whounderwent CABG during the study period.
💡
Sonuç & Katkı:No significant differences in the homocysteine levels (p=0.072) were found both between the patients with low and high LDL-clevels (p=0.345) and between the patients with low and high triglyceride levels.Conclusion: Our study results suggest that homocysteine level is directly associated with AAAs and may be useful to identify patients withan AAA.
🔬Tür:Araştırma Makalesi
📍Kapsam:2015 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: The aim of the present study was to investigate the relationship of homocysteine levels with major atherosclerotic diseases inpatients with coronary artery disease undergoing coronary artery bypass grafting (CABG) and in patients with infrarenal abdominal aorticaneurysms (AAAs).Patients and methods: This prospective, case-control study included a total of 55 patients (35 males, 20 females; median age 64 years; range,42 to 83 years) undergoing CABG and patients with infrarenal AAAs between January 2015 and June 2015. The infrarenal AAA group(n=15) consisted of the patients having an anteroposterior diameter of ≥50 mm and the CABG group (n=20) consisted of the patients whounderwent CABG during the study period. The patients without any known AAA were assigned to the control group (n=20). Homocysteine,low-density lipoprotein cholesterol (LDL-c), and triglyceride levels were analyzed in all groups.Results: Homocysteine levels were significantly higher in the AAA group than both in the CABG group (p=0.039) and in the control group(p=0.011). No significant differences in the homocysteine levels (p=0.072) were found both between the patients with low and high LDL-clevels (p=0.345) and between the patients with low and high triglyceride levels.Conclusion: Our study results suggest that homocysteine level is directly associated with AAAs and may be useful to identify patients withan AAA.

🔖

Bu Makaleye Atıf Yap

ŞEREFLİ, D., SAYDAM, O., METİN, S. K. (2019). Relationship of homocysteine level with abdominal aortic aneurysm and coronary artery disease. Turkish journal of vascular surgery, Cilt: 28 - Sayı: 2, 91–94. https://ajindex.com/articles/375769

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Lawrence PF, Gazak C, Bhirangi L, Jones B, Bhirangi K, Oderich G, et al. The epidemiology of surgically repaired aneurysms in the United States. J Vasc Surg 1999;30:632-40
  2. Rigberg DA, Zingmond DS, McGory ML, Maggard MA, Agustin M, Lawrence PF, et al. Age stratified, perioperative, and one-year mortality after abdominal aortic aneurysm repair: a statewide experience. J Vasc Surg 2006;43:224-9
  3. Owens CD, Conte MS. Atherosclerosis. In: Cronenwett JL, Johnston W, editors. Rutherford’s Vascular Surgery. 7th ed. Vol
  4. Philadelphia: Saunders; 2010. p. 53-68
  5. Zhao J, Chen H, Liu N, Chen J, Gu Y, Chen J, et al. Role of Hyperhomocysteinemia and Hyperuricemia in Pathogenesis of Atherosclerosis. J Stroke Cerebrovasc Dis 2017;26:2695-9
  6. Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 1976;57:1079-82
  7. Brattstrom LE, Hardebo JE, Hultberg BL. Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984;15:1012-6
  8. Clarke R, Halsey J, Bennett D, Lewington S. Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials. J Inherit Metab Dis 2011;34:83-91
  9. Zarins CK, Glagov S, Vesselinovitch D, Wissler RW. Aneurysm formation in experimental atherosclerosis: relationship to plaque evolution. J Vasc Surg 1990;12:246-56
  10. Xu C, Zarins CK, Glagov S. Aneurysmal and occlusive atherosclerosis of the human abdominal aorta. J Vasc Surg 2001;33:91-6
  11. Brunelli T, Prisco D, Fedi S, Rogolino A, Farsi A, Marcucci R, et al. High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg 2000;32:531-6
  12. Warsi AA, Davies B, Morris-Stiff G, Hullin D, Lewis MH. Abdominal aortic aneurysm and its correlation to plasma homocysteine, and vitamins. Eur J Vasc Endovasc Surg 2004;27:75-9
  13. Halazun KJ, Bofkin KA, Asthana S, Evans C, Henderson M, Spark JI. Hyperhomocysteinaemia is associated with the rate of abdominal aortic aneurysm expansion. Eur J Vasc Endovasc Surg 2007;33:391-4
  14. Cao H, Hu X, Zhang Q, Li J, Liu B, Wang J, et al. Hyperhomocysteinaemia, low folate concentrations and MTHFR C677T mutation in abdominal aortic aneurysm. Vasa 2014;43:181-8
  15. Arnesen E, Refsum H, Bønaa KH, Ueland PM, Førde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995;24:704-9.